Chronic Lymphocytic Leukemia Study

A CLL Research Consortium (CRC) Phase II Study of Kinetic Biomarker for Chronic Lymphocytic (CLL) Prognosis

Protocol ID

05.06.067

Protocol Description

In patients with leukemia, blood cells (both normal cells and leukemic cells) are produced in the bone marrow to replace cells that have died or been removed.  This process of replacement is called cell turnover.  This study will look at the cell turnover of leukemia cells in patients with chronic lymphocytic leukemia using a method to measure the production and destruction rates of cells. 

Eligibility Criteria

Patients with chronic lymphocytic leukemia

Primary Investigator(s)

  • Kanti Rai, MD

Contact Information

Dale Janson, RPA-C
(718) 470-4408
djanson@lij.edu

Last Update

March 26, 2010
  • Share this Page
  • Bookmark this Page
  • Toggle Text Size
  • Print this Page
Search Cancer:
top